UBS reduced its holdings in SSY GROUP (02005) by 37,200 shares at a price of approximately HK$3.24 per share.
On February 21, UBS reduced its stake in Sino Biopharmaceutical (02005) by 372,000 shares, with a price of HK$3.2439 per share.
According to the latest data from the Hong Kong Stock Exchange, on February 21st, UBS reduced its holdings of SSY GROUP (02005) by 372,000 shares, with a price of 3.2439 Hong Kong dollars per share, totaling approximately 1.2067 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 265 million shares, with a new shareholding percentage of 8.98%.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
